Advertisement
Research Article|Articles in Press

Effectiveness of Internet-based health management in patients with dyslipidemia: A four-year longitudinal study

      Highlights

      • Internet-based health management and intervention can improve the awareness rate and control rate of dyslipidemia.
      • By guiding individuals through the Internet health management platform, their health-related behaviors that are beneficial to health (tobacco use, physical activity, and partial dietary) were gradually improved over the intervention time.
      • Serum cholesterol and triglyceride of patients with dyslipidemia decreased year by year over the intervention time.

      Abstract

      Background and aims

      Dyslipidemia is an important risk factor for coronary artery disease and stroke, and it has emerged as a major public health issue worldwide. Internet-based health management and intervention may offer a new approach to health management. This study was conducted to provide health guidance and education to people with dyslipidemia using an Internet health management platform and to assess the effectiveness of Internet health management and intervention in improving health-related behaviors and controlling blood lipids.

      Methods

      Starting in 2013 (Baseline, N = 56,542), a Western longitudinal study in China was performed, and all interventional objects were provided with Internet health management. Health checkups were conducted annually, and questionnaires were administered every two years to analyze changes in health behaviors two years (2015) and four years (2017) following the intervention. In addition, factors affecting behavioral changes and lipid control were analyzed in the dyslipidemic population to understand the effectiveness and influencing factors of Internet health management on lipid control.

      Results

      By guiding interventional objects through the Internet health management platform, the awareness rate of dyslipidemia increased from 19.1% in 2013 to 34.4% in 2017; and the control rate of dyslipidemia increased from 9.1% at baseline to 18.5%. Certain health-related behaviors that are beneficial to health (tobacco use, physical activity, and partial dietary) were gradually improved over the intervention time. For patients with dyslipidemia, triglyceride decreased from 2.90 mmol/L (2013) to 2.77 mmol/L (2017) as the years went by. Analysis of factors affecting lipid control showed that non-compliance with health instructions affected lipid control; in addition to these, being female (0.722, 95% CI: 0.546,0.954) was found to be a protective factor for effective lipid control.

      Conclusions

      The basic Internet-based health management platform in this study appears to be moderately successful and is a valuable and feasible application. Tobacco, dietary, and physical activity interventions provided significant protection against dyslipidemia in patients.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. 2016 Chinese guidelines for the management of dyslipidemia in adults.
        J. Geriatr. Cardiol. 2018; 15: 1-29
      2. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2019.
        Diabetes Care. 2019; 42: S103-S123
        • Rosamond W.
        • Flegal K.
        • Friday G.
        • Furie K.
        • Go A.
        • Greenlund K.
        • Haase N.
        • Ho M.
        • Howard V.
        • Kissela B.
        • Kittner S.
        • Lloyd-Jones D.
        • McDermott M.
        • Meigs J.
        • Moy C.
        • Nichol G.
        • O'Donnell C.J.
        • Roger V.
        • Rumsfeld J.
        • Sorlie P.
        • Steinberger J.
        • Thom T.
        • Wasserthiel-Smoller S.
        • Hong Y.
        Heart disease and stroke statistics--2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee.
        Circulation. 2007; 115: e69-e171
        • Song P.
        • Zha M.
        • Yang X.
        • Xu Y.
        • Wang H.
        • Fang Z.
        • Yang X.
        • Xia W.
        • Zeng C.
        Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese.
        Atherosclerosis. 2019; 282: 57-66
        • Guo Q.
        • Ma Z.
        • Zhu C.
        • Zeng Q.
        Association of dietary pattern and physical activity with lipid-related indices among Chinese population: a cross-sectional study.
        Lipids Health Dis. 2020; 19
        • Kopin L.
        • Lowenstein C.
        Dyslipidemia.
        Ann. Intern. Med. 2017; 167: C81-C96
        • He H.
        • Yu Y.Q.
        • Li Y.
        • Kou C.G.
        • Li B.
        • Tao Y.C.
        • Zhen Q.
        • Wang C.
        • Kanu J.S.
        • Huang X.F.
        • Han M.
        • Liu Y.W.
        Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.
        Lipids Health Dis. 2014; 13: 122
        • Song P.
        • Zha M.
        • Yang X.
        • Xu Y.
        • Wang H.
        • Fang Z.
        • Yang X.
        • Xia W.
        • Zeng C.
        Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese.
        Atherosclerosis. 2019; 282: 57-66
        • Huang Y.
        • Gao L.
        • Xie X.
        • Tan S.C.
        Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control.
        Popul. Health Metr. 2014; 12: 28
        • Opoku S.
        • Gan Y.
        • Yobo E.A.
        • Tenkorang-Twum D.
        • Yue W.
        • Wang Z.
        • Lu Z.
        Awareness, Treatment, Control, and Determinants of Dyslipidemia Among Adults in China.
        SCI REP-UK, 2021: 11
        • Klingman D.
        • Williams S.A.
        • Benner J.S.
        • Smith T.W.
        • Ahn J.
        • O'Donnell J.C.
        Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 national health and nutrition examination survey.
        Am. Heart J. 2005; 150: 595-601
        • Valuck R.J.
        • Williams S.A.
        • MacArthur M.
        • Saseen J.J.
        • Nair K.V.
        • McCollum M.
        • Ensor J.E.
        A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization.
        Clin. Ther. 2003; 25: 2936-2957
        • Hofmann M.
        • Dack C.
        • Barker C.
        • Murray E.
        • Nitin G.
        • Gupta N.
        The impact of an internet-based self-management intervention (HeLP-Diabetes) on the psychological well-being of adults with type 2 diabetes: a mixed-method cohort study.
        J. Diabetes Res. 2015; 2016: 1476313-1476384
        • Chen Y.
        • Tsao L.
        • Huang C.
        • Yu Y.
        • Liu I.
        • Jou H.
        An Internet-based health management platform may effectively reduce the risk factors of metabolic syndrome among career women.
        Taiwan. J. Obstet. Gynecol. 2013; 52: 215-221
        • Pan L.
        • Yang Z.
        • Wu Y.
        • Yin R.X.
        • Liao Y.
        • Wang J.
        • Gao B.
        • Zhang L.
        The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
        Atherosclerosis. 2016; 248: 2-9
      3. Executive summary of the third report of the national cholesterol education program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Wang S.S.
        • Lay S.
        • Yu H.N.
        • Shen S.R.
        Dietary guidelines for Chinese residents (2016): comments and comparisons.
        J. Zhejiang Univ. - Sci. B. 2016; 17: 649-656
        • Fan M.
        • Lyu J.
        • He P.
        [Chinese guidelines for data processing and analysis concerning the International Physical Activity Questionnaire].
        Zhonghua Liuxingbingxue Zazhi. 2014; 35: 961-964
        • Wang L.M.
        • Mi S.Q.
        • Zhang M.
        • Li Y.C.
        • Jiang Y.
        • Xu Y.
        • Dai M.
        • Wang L.H.
        [Awareness rate,treatment rate and control rate of dyslipidemia in Chinese adults], 2010.
        Chin. J. Prev. Med. 2012; 46: 687-691
        • Zhang X.M.
        [The influence of continuous person-centered health education on populations with dyslipidemia].
        Labeled immunoassays and clinical medicine. 2019; 26: 1434-1437
        • Bak A.A.
        • Huizer J.
        • Leijten P.A.
        • Rila H.
        • Grobbee D.E.
        Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.
        J. Intern. Med. 1998; 244: 371-378
        • Omboni S.
        • Campolo L.
        • Panzeri E.
        Telehealth in chronic disease management and the role of the Internet-of-Medical-Things: the Tholomeus(R) experience.
        Expet Rev. Med. Dev. 2020; 17: 659-670
        • Seo D.C.
        • Niu J.
        Evaluation of internet-based interventions on waist circumference reduction: a meta-analysis.
        J. Med. Internet Res. 2015; 17: e181
        • Liu X.
        • Yu S.
        • Mao Z.
        • Li Y.
        • Zhang H.
        • Yang K.
        • Zhang H.
        • Liu R.
        • Qian X.
        • Li L.
        • Bie R.
        • Wang C.
        Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.
        Lipids Health Dis. 2018; 17: 119
        • Cai L.
        • Zhang L.
        • Liu A.
        • Li S.
        • Wang P.
        Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China.
        J. Atheroscler. Thromb. 2012; 19: 159-168
        • Goff D.J.
        • Bertoni A.G.
        • Kramer H.
        • Bonds D.
        • Blumenthal R.S.
        • Tsai M.Y.
        • Psaty B.M.
        Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.
        Circulation. 2006; 113: 647-656
        • Imamura H.
        • Miyamoto N.
        • Uchida K.
        • Teshima K.
        • Masuda Y.
        • Kobata D.
        Cigarette smoking, blood pressure and serum lipids and lipoproteins in middle-aged women.
        J. Physiol. Anthropol. Appl. Hum. Sci. 2001; 20: 1-6
        • Takata K.
        • Imaizumi S.
        • Kawachi E.
        • Suematsu Y.
        • Shimizu T.
        • Abe S.
        • Matsuo Y.
        • Tsukahara H.
        • Noda K.
        • Yahiro E.
        • Zhang B.
        • Uehara Y.
        • Miura S.
        • Saku K.
        Impact of cigarette smoking cessation on high-density lipoprotein functionality.
        Circ. J. 2014; 78: 2955-2962
        • Nakamura K.
        • Barzi F.
        • Huxley R.
        • Lam T.H.
        • Suh I.
        • Woo J.
        • Kim H.C.
        • Feigin V.L.
        • Gu D.
        • Woodward M.
        Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?.
        Heart. 2009; 95: 909-916
        • Ho H.V.
        • Sievenpiper J.L.
        • Zurbau A.
        • Blanco M.S.
        • Jovanovski E.
        • Au-Yeung F.
        • Jenkins A.L.
        • Vuksan V.
        A systematic review and meta-analysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction(i-iv).
        Eur. J. Clin. Nutr. 2016; 70: 1239-1245
        • Whitehead A.
        • Beck E.J.
        • Tosh S.
        • Wolever T.M.
        Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials.
        Am. J. Clin. Nutr. 2014; 100: 1413-1421
        • Akesson A.
        • Weismayer C.
        • Newby P.K.
        • Wolk A.
        Combined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in women.
        Arch. Intern. Med. 2007; 167: 2122-2127
        • Ursoniu S.
        • Sahebkar A.
        • Serban M.C.
        • Antal D.
        • Mikhailidis D.P.
        • Cicero A.
        • Athyros V.
        • Rizzo M.
        • Rysz J.
        • Banach M.
        Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials.
        Nutr. Rev. 2017; 75: 361-373
        • Delgado-Lista J.
        • Perez-Jimenez F.
        • Ruano J.
        • Perez-Martinez P.
        • Fuentes F.
        • Criado-Garcia J.
        • Parnell L.D.
        • Garcia-Rios A.
        • Ordovas J.M.
        • Lopez-Miranda J.
        Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.
        J. Lipid Res. 2010; 51: 63-73
        • Lopez-Miranda J.
        • Cruz G.
        • Gomez P.
        • Marin C.
        • Paz E.
        • Perez-Martinez P.
        • Fuentes F.J.
        • Ordovas J.M.
        • Perez-Jimenez F.
        The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism.
        J. Clin. Endocrinol. Metab. 2004; 89: 4721-4728
        • Torris C.
        • Smastuen M.C.
        • Molin M.
        Nutrients in fish and possible associations with cardiovascular disease risk factors in metabolic syndrome.
        Nutrients. 2018; 10
        • Kritchevsky S.B.
        A review of scientific research and recommendations regarding eggs.
        J. Am. Coll. Nutr. 2004; 23: 596S-600S
        • Blesso C.N.
        • Andersen C.J.
        • Barona J.
        • Volek J.S.
        • Fernandez M.L.
        Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome.
        Metabolism. 2013; 62: 400-410
        • Buil-Cosiales P.
        • Toledo E.
        • Salas-Salvado J.
        • Zazpe I.
        • Farras M.
        • Basterra-Gortari F.J.
        • Diez-Espino J.
        • Estruch R.
        • Corella D.
        • Ros E.
        • Marti A.
        • Gomez-Gracia E.
        • Ortega-Calvo M.
        • Aros F.
        • Monino M.
        • Serra-Majem L.
        • Pinto X.
        • Lamuela-Raventos R.M.
        • Babio N.
        • Gonzalez J.I.
        • Fito M.
        • Martinez-Gonzalez M.A.
        Association between dietary fibre intake and fruit, vegetable or whole-grain consumption and the risk of CVD: results from the PREvencion con DIeta MEDiterranea (PREDIMED) trial.
        Br. J. Nutr. 2016; 116: 534-546
        • Crichton G.E.
        • Alkerwi A.
        Physical activity, sedentary behavior time and lipid levels in the Observation of Cardiovascular Risk Factors in Luxembourg study.
        Lipids Health Dis. 2015; 14: 87
        • Leclerc S.
        • Allard C.
        • Talbot J.
        • Gauvin R.
        • Bouchard C.
        High density lipoprotein cholesterol, habitual physical activity and physical fitness.
        Atherosclerosis. 1985; 57: 43-51
        • Wang Y.
        • Xu D.
        Effects of aerobic exercise on lipids and lipoproteins.
        Lipids Health Dis. 2017; 16: 132